Properties (97)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:XYZ_Pharma
|
| gptkbp:advertising |
gptkb:Ms._Emily_White
Mr._Alan_Brown |
| gptkbp:awards |
Best Workplace 2022
|
| gptkbp:CEO |
gptkb:John_Doe
|
| gptkbp:clinicalTrials |
Active
Completed Ongoing Pending Approved Terminated Withdrawn Suspended Phase III Trials Recruiting Completed with Results Not Yet Recruiting Results Advocated Results Affirmed Results Analyzed Results Available Results Confirmed Results Disclosed Results Discouraged Results Dismissed Results Endorsed Results Ignored Results Interpreted Results Misapprehended Results Misassessed Results Misattributed Results Miscalculated Results Misclassified Results Miscommunicated Results Misestimated Results Misinterpreted Results Misjudged Results Misreported Results Misrepresented Results Misunderstood Results Not Disclosed Results Not Published Results Not Shared Results Opposed Results Overlooked Results Pending Results Promoted Results Published Results Refuted Results Reviewed Results Shared Results Supported Results Validated Results Verified Results_Contradicted Results_Critiqued Results_Misconstrued Results_Misconveyed Results_Misidentified Results_Misquoted Results_Misvalued |
| gptkbp:community_involvement |
Health Education Programs
|
| gptkbp:employees |
5000
|
| gptkbp:focus |
Innovative Therapies
|
| gptkbp:founded |
2001
|
| gptkbp:headquarters |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
AIG Global Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:internationalCooperation |
10
|
| gptkbp:investmentFocus |
$200 million in R&D
|
| gptkbp:market |
Global
|
| gptkbp:mission |
Improve_Global_Health
|
| gptkbp:partnerships |
Universities
Various Healthcare Organizations |
| gptkbp:patentCitation |
Over 100
|
| gptkbp:products |
Prescription Drugs
|
| gptkbp:regulates |
FDA_Approved
|
| gptkbp:research |
gptkb:Dr._Jane_Smith
Clinical Trials |
| gptkbp:research_areas |
Cardiology
Oncology Diabetes Neurology Infectious Diseases |
| gptkbp:revenue |
$1 billion
|
| gptkbp:services |
Research_and_Development
|
| gptkbp:social_media |
LinkedIn
|
| gptkbp:subsidiary |
AIG_Biotech
|
| gptkbp:sustainability |
Green Initiatives
|
| gptkbp:values |
Accountability
Collaboration Integrity Respect Excellence |
| gptkbp:vision |
Leading in Innovation
|
| gptkbp:website |
www.aigglobalpharma.com
|